RecruitingNot ApplicableNCT07579585

Effects of Photobiomodulation in Hemophilia Patients.

Effects of Photobiomodulation on Knee Hemarthosis in Patients With Hemophilia.

Sponsor

Riphah International University

Enrollment

24 participants

Start Date

Apr 5, 2026

Study Type

INTERVENTIONAL

Conditions

Hemophilia Hemarthrosis, Knee

Summary

Hemophilia is a genetic bleeding disorder that commonly leads to knee hemarthrosis, causing pain, swelling, and reduced joint mobility in children. While standard treatments include clotting factor replacement and physiotherapy, additional non-invasive approaches are being explored. This study aims to evaluate the effects of photobiomodulation on knee hemarthrosis in male hemophilia patients aged 9-14 years. It focuses on determining whether this therapy can reduce pain and swelling and improve joint range of motion when used alongside

Eligibility

Min Age: 9 YearsMax Age: 14 Years

Inclusion Criteria3

Hemophilia patients with knee hemarthosis
Patients of age 9-14 yrs will be taken
Bothmaleand female population will be included

Exclusion Criteria5

Presence of open wounds at or near the treatment site.
Kneejoint subluxation.
Presence of congenital or acquired skeletal deformities.
Children diagnosed with cardiopulmonary dysfunctions.
Children with neurological deficits

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONphotobiomodulation

Photobiomodulation is a non-invasive therapy that uses low-level light (typically from lasers or LEDs) to stimulate cellular activity and promote healing. It works by enhancing mitochondrial function, increasing energy (ATP) production, and reducing inflammation. This therapy is commonly used for pain relief, tissue repair, and improving recovery in various clinical conditions.